Micronutrient Antioxidants for Men (Menevit®) Improve Sperm Function by Reducing Oxidative Stress, Resulting in Improved Assisted Reproductive Technology Outcomes
Open Access
- 23 May 2024
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 13 (6) , 635
Abstract
Oxidative stress (OS) affects men’s health and impairs spermatogenesis. Micronutrient antioxidants are available for male infertility as complemental support; however, their efficacy remains debatable. This study aimed to investigate whether antioxidants can help to reduce sperm OS and improve semen analysis and quality. We included 171 male partners of couples planning to undergo assisted reproductive technology (ART). Male partners, aged 29–41 years, of couples intending to conceive were self-selected to take daily antioxidants (n = 84) containing folic acid and zinc, or not to take antioxidants (n = 52) for 6 months. We analyzed the alterations in serum oxidant levels, sperm parameters, OS, and deoxyribonucleic acid fragmentation after 3 and 6 months. Additionally, implantation, clinical pregnancy, and miscarriage rates after vitrified–warmed embryo transfer were compared between those taking antioxidants and those not taking them after 6 months. In men with high static oxidation–reduction potential (sORP), we observed a significant improvement in sperm concentration and sORP. The high-quality blastocyst rate tended to increase, and implantation and clinical pregnancy rates also significantly increased after 6 months of intervention. The micronutrient antioxidants could improve sperm function by reducing OS and improving ART outcomes. Therefore, micronutrient antioxidants may be a viable treatment option for male infertility.Keywords
This publication has 88 references indexed in Scilit:
- Reduction of Plasma Homocyst(e)ine Levels by Breakfast Cereal Fortified with Folic Acid in Patients with Coronary Heart DiseaseNew England Journal of Medicine, 1998
- Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration.1998
- Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione PeroxidaseJournal of Biological Chemistry, 1997
- A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertilityFertility and Sterility, 1995
- Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acidJournal of Internal Medicine, 1995
- Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive diseaseEuropean Journal of Clinical Investigation, 1995
- Vitamin Requirements for the Treatment of Hyperhomocysteinemia in HumansThe Journal of Nutrition, 1994
- Treatment of mild hyperhomocysteinemia in vascular disease patients.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Oxidants, antioxidants, and the degenerative diseases of aging.Proceedings of the National Academy of Sciences, 1993
- Folic acid—an innocuous means to reduce plasma homocysteineScandinavian Journal of Clinical and Laboratory Investigation, 1988